Home  »  Technologies   »  Tenax Therapeutics Inc. (NASDAQ:TENX) Shares Surge...

Tenax Therapeutics Inc. (NASDAQ:TENX) Shares Surges 15.00% In A Week – But Can It Keep Rising?

In last trading session, Tenax Therapeutics Inc. (NASDAQ:TENX) saw 6.42 million shares changing hands with its beta currently measuring 1.95. Company’s recent per share price level of $0.14 trading at $0.02 or 11.29% at ring of the bell on the day assigns it a market valuation of $4.91M. That closing price of TENX’s stock is at a discount of -942.86% from its 52-week high price of $1.46 and is indicating a premium of 42.86% from its 52-week low price of $0.08. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 16.93 million shares which gives us an average trading volume of 3.92 million if we extend that period to 3-months.

For Tenax Therapeutics Inc. (TENX), analysts’ consensus is at an average recommendation of a Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.08 in the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Tenax Therapeutics Inc. (NASDAQ:TENX) trade information

Upright in the green during last session for gaining 11.29%, in the last five days TENX remained trading in the green while hitting it’s week-highest on Friday, 11/18/22 when the stock touched $0.14 price level, adding 10.83% to its value on the day. Tenax Therapeutics Inc.’s shares saw a change of -86.73% in year-to-date performance and have moved 15.00% in past 5-day. Tenax Therapeutics Inc. (NASDAQ:TENX) showed a performance of -8.85% in past 30-days. Number of shares sold short was 0.2 million shares which calculate 0.28 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $5.00 to the stock, which implies a rise of 97.2% to its current value. Analysts have been projecting $5.00 as a low price target for the stock while placing it at a high target of $5.00. It follows that stock’s current price would drop -3471.43% in reaching the projected high whereas dropping to the targeted low would mean a loss of -3471.43% for stock’s current value.

Tenax Therapeutics Inc. (TENX) estimates and forecasts

Statistics highlight that Tenax Therapeutics Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -76.22% of value to its shares in past 6 months, showing an annual growth rate of 74.68% while that of industry is 4.40. Apart from that, the company came raising its revenue forecast for fiscal year 2022.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 44.80% during past 5 years.

TENX Dividends

Tenax Therapeutics Inc. is more likely to be releasing its next quarterly report on November 10 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Tenax Therapeutics Inc. (NASDAQ:TENX)’s Major holders

Insiders are in possession of 20.43% of company’s total shares while institution are holding 16.30 percent of that, with stock having share float percentage of 20.48%. Investors also watch the number of corporate investors in a company very closely, which is 16.30% institutions for Tenax Therapeutics Inc. that are currently holding shares of the company. Gofen & Glossberg LLC is the top institutional holder at TENX for having 3.82 million shares of worth $0.53 million. And as of Sep 29, 2022, it was holding 8.54% of the company’s outstanding shares.

The second largest institutional holder is Armistice Capital, LLC, which was holding about 1.97 million shares on Sep 29, 2022. The number of shares represents firm’s hold over 4.40% of outstanding shares, having a total worth of $0.27 million.

On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 0.18 million shares of worth $24626.0 or 0.40% of the total outstanding shares. The later fund manager was in possession of 0.17 million shares on Jun 29, 2022, making its stake of worth around $23984.0 in the company or a holder of 0.39% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]